Jia-fu SUN, Xiao SUN, Yun LUO, et al. Protective Effect of Salvianolic Acid B on Arsenic Trioxide-induced HepaRG Human Hepatocyte Injury[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(8): 68-74.
DOI:
Jia-fu SUN, Xiao SUN, Yun LUO, et al. Protective Effect of Salvianolic Acid B on Arsenic Trioxide-induced HepaRG Human Hepatocyte Injury[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(8): 68-74. DOI: 10.13422/j.cnki.syfjx.20200821.
Protective Effect of Salvianolic Acid B on Arsenic Trioxide-induced HepaRG Human Hepatocyte Injury
To investigate the protective effect of salvianolic acid B on HepaRG hepatocyte injury induced by arsenic trioxide (As
2
O
3
) and its mechanism.
Method:
2
HepaRG cells were incubated with 5μmol·L
-1
As
2
O
3
for 24 h to induce hepatocyte injury. The cells were divided into control group
model group
salvianolic acid B 10 μmol·L
-1
group
salvianolic acid B 10 μmol·L
-1
+ As
2
O
3
group
salvianolic acid B 5 μmol·L
-1
+ As
2
O
3
group
and salvianolic acid B 2.5 μmol·L
-1
+ As
2
O
3
group. HepaRG cells were preincubated with salvianolic acid B for 2 h and then incubated with As
2
O
3
for 24 h. At the end of the incubation
cell viability was detected by thiazolyl blue tetrazolium bromide assay
apoptosis was observed by Hoechst33342 fluorescence staining
apoptosis rate was detected by annexin V-FITC/propidium iodide double staining flow cytometry
and mitochondrial membrane was observed by JC-1 fluorescence staining. Western blot was used to detect the protective effect of expressions of relevant proteins Bcl-2
Bax
Akt
p-Akt on salvianolic acid B in the liver.
Result:
2
As
2
O
3
concentration-dependently reduced the survival rate of HepaRG cells(
P
<
0.01)
salvianolic acid B had no effect on normal cell viability for 2 h
pre-incubation with salvianolic acid B(5
10 μmol·L
-1
) for 2 h significantly increased the decreased cell survival rate caused by As
while pre-incubation with salvianolic acid B(10 μmol·L
-1
) deceased apoptosis rate(
P
<
0.01). Incubation with As
2
O
3
for 24 h caused decrease of mitochondrial membrane potential
pre-incubation with salvianolic acid B maintained mitochondrial membrane potential
indicating that the anti-apoptotic effect of salvianolic acid B were related to the mitochondrial pathway modulation. Western blot analysis showed that salvianolic acid B promoted the ratio of Bcl-2/Bax and promoted p-Akt/Akt compared with As
2
O
3
group(
P
<
0.01).
Conclusion:
2
Salvianolic acid B has a protective effect on hepatocyte injury induced by As
2
O
3
and its mechanism is related to maintenance of mitochondrial function and inhibition of hepatocyte apoptosis.
关键词
Keywords
references
M R O'DONNELL , F R APPELBAUM , M R BAER , et al . Acute myeloid leukemia clinical practice guidelines in oncology [J]. J Natl Compr Canc Netw , 2006 , 4 ( 1 ): 16 - 36 .
E LENGFELDER , W K HOFMANN , D NOWAK . Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia [J]. Leukemia , 2012 , 26 ( 3 ): 433 - 442 .
M KITO , Y AKAO , N OHISHI , et al . Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines [J]. Biochem Bioph Res Co , 2002 , 291 ( 4 ): 861 - 867 .
D ACOSTA , E M SORENSEN , D C ANUFORO , et al . An in vitro approach to the study of target organ toxicity of drugs and chemicals [J]. In Vitro Cell Dev Biol , 1985 , 21 ( 9 ): 495 - 504 .
V MATHEWS , S DESIRE , B GEORGE , et al . Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity [J]. Leukemia , 2006 , 20 ( 5 ): 881 - 883 .
V MATHEWS , B GEORGE , E CHENDAMARAI , et al . Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data [J]. J Clin Oncol , 2010 , 28 ( 24 ): 3866 - 3871 .
V V MATHEWS , P BINU , S M PAUL , et al . Hepatoprotective efficacy of curcumin against arsenic trioxide toxicity [J]. Asian Pac J Trop Biomed , 2012 , 2 ( 2 ): 706 - 711 .
L C HAO , J S ZHAO , X L WANG , et al . Hepatotoxicity from arsenic trioxide for pediatric acute promyelocytic leukemia [J]. J Pediat Hematol Onc , 2013 , 35 ( 2 ): 67 - 70 .
F LO-COCO , G AVVISATI , M VIGNETTI , et al . Retinoic acid and arsenic trioxide for acute promyelocytic leukemia [J]. N Engl J Med , 2013 , 369 ( 2 ): 111 - 121 .
A K BURNETT , N H RUSSELL , R K HILLS , et al . Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial [J]. Lancet Oncol , 2015 , 16 ( 13 ): 1295 - 1305 .
J Y ZHANG , B ZHANG , M WANG , et al . Calcium homeostasis and endoplasmic reticulum stress are involved in salvianolic acid B-offered protection against cardiac toxicity of arsenic trioxide [J]. Oncotarget , 2017 , 8 ( 57 ): 97384 - 97393 .
M WANG , G B SUN , P WU , et al . Salvianolic acid B prevents arsenic trioxide-induced cardiotoxicity in vivo and enhances its anticancer activity in vitro [J]. Evid-Based Compl Alt , 2013 , 2013 ( 3 ): 759483 .
M WANG , G B SUN , X B SUN , et al . Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway [J]. Toxicol Lett , 2013 , 216 ( 2/3 ): 100 - 107 .